Literature DB >> 6390687

Clinical pharmacology of daunorubicin in patients with acute leukemia.

C E Riggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6390687

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: relationship with leukocytopenia and neutropenia.

Authors:  T Fukushima; T Yamashita; N Goto; T Ueda; K I Okabe; Y Kuraishi; R Ohno; A Urabe; M Ogawa
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.

Authors:  D L de Valeriola; D D Ross; A Forrest; D P Cuddy; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Clinical pharmacology of 4-demethoxydaunorubicin (DMDR).

Authors:  K Lu; N Savaraj; J Kavanagh; L G Feun; M Burgess; G P Bodey; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.